The rising incidence of tongue cancer in people without traditional risk factors represents a potentially significant shift in oral cancer epidemiology. This molecular detective work could reshape how oncologists approach diagnosis and treatment for patients who develop oral cancers despite never smoking, drinking excessively, or carrying HPV infections.
Analyzing genomic data from 253 oral cavity cancers and 94 laryngeal cancers, researchers identified distinct mutational fingerprints that separate tumors by their underlying biological drivers. Traditional tobacco-related oral cancers displayed the expected SBS16 signature, reflecting DNA damage from combined smoking and alcohol exposure. However, tongue cancers in patients with no identifiable risk factors split into two molecularly distinct subtypes: one characterized by accelerated "clock-like" cellular aging processes, and another dominated by APOBEC enzyme activity that typically responds to viral infections or cellular stress.
These findings suggest that tongue cancer in younger, healthier populations may arise through fundamentally different biological pathways than previously understood. The clock-like subtype implies that some individuals may have inherited or acquired defects in cellular maintenance systems, while the APOBEC-driven subtype points to inflammatory or immune-mediated processes. Both subtypes showed unique patterns of tumor suppressor gene mutations and DNA methylation changes, indicating they represent genuine biological entities rather than statistical artifacts. This molecular classification system could enable more precise treatment selection and help identify environmental or genetic factors driving the unexplained rise in tongue cancer rates.